📋 ADAGIO MEDICAL HOLDINGS, INC. (ADGM) - Financial Results
Filing Date: 2026-08-11
Accepted: 2026-08-11 08:30:36
Event Type: Financial Results
Event Details:
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) Reports the reporting period Financial Results
ADAGIO MEDICAL HOLDINGS, INC. (ADGM) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: 4934
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 7740
generation vCLASTM Ultra Ultra
Low temperature ablation catheter (“ULTA”), which is designed to be faster and more maneuverable than the first generation vCLASTM Ventricular Ablation System catheter, under Expanded Access authorization from the U.S. Food and Drug Administration (“FDA”) ·Announced pivotal results from the 209
📋 ADAGIO MEDICAL HOLDINGS, INC. (ADGM) - Financial Results
Filing Date: 2026-08-11
Accepted: 2026-08-11 08:30:36
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: